PAH occurs when there is profound vasculopathy (vasoconstriction, vascular remodelling & in situ thrombosis) → endothelial dysfunction → decreased vasodilator production → increased pro-contractile mediators, increased growth factor release, increase pro-inflammatory cytokine release → increased contractility of arteries, dysfunction of endothelium, over-proliferation of endothelial cells & vascular smooth muscle cells & increased thrombotic risk → increased pulmonary vascular resistance → increased pulmonary artery pressure